There is evidence to suggest that the protective, antioxidant effects of GSTM1 are of greater importance in a uremic environment (i.e., at lower GFR), and this may account for the disparity between risk of incident CKD and kidney failure in this cohort.8 This evidence concerns the gene GSTM1 and chronic kidney disease.